Mrs Emily Elizabeth Key, OTR/L | |
136 N 3 Mile Rd, Fort Gibson, OK 74434-7727 | |
(918) 680-1237 | |
Not Available |
Full Name | Mrs Emily Elizabeth Key |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 136 N 3 Mile Rd, Fort Gibson, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013359983 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 1836 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Emily Elizabeth Key, OTR/L 10321 N 2274 Rd, Clinton, OK 73601-7521 Ph: () - | Mrs Emily Elizabeth Key, OTR/L 136 N 3 Mile Rd, Fort Gibson, OK 74434-7727 Ph: (918) 680-1237 |
News Archive
The findings are the result of extensive research funded by the Medical Research Council, the Department of Health and the Home Office, and carried out by Dr. Essi Viding of the MRC Social, Genetic and Developmental Psychiatry Centre, within the Institute of Psychiatry, King's College London.
Researchers have found possible blood biomarkers for suicidal behavior that could help identify psychiatric patients at risk.
Implementing bundled payments for total joint replacements resulted in year-over-year improvements in quality of care and patient outcomes while reducing overall costs, according to a new three-year study from NYU Langone Medical Center.
Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.
Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC).
› Verified 6 days ago
The Therapy House Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 136 N 3 Mile Rd, Fort Gibson, OK 74434 Phone: 918-680-1237 | |
Janet Hulbert, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1409 Saddlebrooke Dr, Fort Gibson, OK 74434 Phone: 918-869-7613 | |
Marjorie Lisa Butikofer, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 418 S East St, Fort Gibson, OK 74434 Phone: 918-478-4480 Fax: 918-478-4480 | |
Timber Hardbarger, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 799 S Lee St, Fort Gibson, OK 74434 Phone: 918-616-8490 |